
Monday, February 26, 2018 9:47:50 AM
All my posts are in my opinion only,do your own DD and don't spend more then you can afford to lose
Recent MNKD News
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 02/26/2025 09:50:27 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2025 09:10:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2025 09:07:08 PM
- MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/26/2025 09:05:00 PM
- MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025 • GlobeNewswire Inc. • 02/19/2025 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2025 02:30:04 AM
- MannKind to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 02/06/2025 09:05:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2025 02:00:03 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/06/2025 10:09:57 PM
- MannKind Expands Executive Leadership Team • GlobeNewswire Inc. • 01/06/2025 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2024 12:00:30 PM
- MannKind Corporation Announces Exchange of Convertible Notes for Stock and Cash • GlobeNewswire Inc. • 12/18/2024 12:00:00 PM
- MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®) • GlobeNewswire Inc. • 12/16/2024 11:05:00 AM
- CDSCO Approves Afrezza® (insulin human) Inhalation Powder in India • GlobeNewswire Inc. • 12/11/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/26/2024 02:30:07 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/22/2024 09:08:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2024 02:30:04 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/15/2024 09:01:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2024 02:30:04 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:06:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:05:13 PM
- MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/07/2024 09:02:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/06/2024 09:04:14 PM
- MannKind to Present at 2024 UBS Healthcare Conference • GlobeNewswire Inc. • 11/05/2024 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/05/2024 02:00:03 AM
VAYK Proposes 100 million Buyback through Private Repurchases • VAYK • Feb 28, 2025 9:00 AM
ConnectM Eliminates an Additional $1.9 Million of Debt • CNTM • Feb 27, 2025 4:01 PM
Consumer Automotive Finance, Inc. Announces Nationwide Teleconference as It Transitions to Fifty 1 Labs, Inc. • CAFI • Feb 27, 2025 9:00 AM
VPR Brands Secures Settlement Agreement With POP Vapor, Reinforcing Commitment to Intellectual Property Protection • VPRB • Feb 27, 2025 8:49 AM
Wytec Begins Sales of Its Multi-Government AI Threat Detection Sensor Technology • WYTC • Feb 27, 2025 7:05 AM
VAYK Issues Clerical Correction to Feb 18 News Regarding Shareholder Premium • VAYK • Feb 26, 2025 10:32 AM